HCA Healthcare, Inc.(HCA)Earnings, Financials & Key Ratios

HCA•NYSE

$428.79

$95.86B mkt cap·15.1× P/E·Price updated May 6, 2026

SectorHealthcare IndustryHealthcare Facilities Sub-IndustryHospitals and inpatient facilities

AboutHCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.Show more

Revenue$75.6B+7.1%
EBITDA$15.49B+11.8%
Net Income$6.78B+17.8%
EPS (Diluted)28.38+29.0%
Gross Margin41.5%+2.2%
EBITDA Margin20.49%+4.4%
Operating Margin15.83%+5.9%
Net Margin8.97%+10.0%
ROIC19.89%+7.9%
Interest Coverage5.37+4.6%

Analysis→Technical→

HCA Key Insights

HCA Healthcare, Inc. (HCA) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Excellent 3Y average ROE of 887.8%
✓Strong Piotroski F-Score: 7/9
✓High quality earnings: Operating CF exceeds net income
✓Share count reduced 11.9% through buybacks
✓Efficient asset utilization: 1.2x turnover

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

HCA Price & Volume

HCA Healthcare, Inc. (HCA) stock price & volume — 10-year historical chart

Loading chart...

HCA Growth Metrics

HCA Healthcare, Inc. (HCA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years6.66%

5 Years7.97%

3 Years7.87%

TTM7.08%

Profit CAGR

10 Years12.29%

5 Years12.56%

3 Years6.33%

TTM17.78%

EPS CAGR

10 Years18.98%

5 Years21.03%

3 Years14.01%

TTM29.06%

Return on Capital

10 Years22.38%

5 Years23.84%

3 Years24.45%

Last Year26.98%

HCA Recent Earnings

HCA Healthcare, Inc. (HCA) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 11/12 qtrs (92%)●Beat Revenue 10/12 qtrs (83%)

Q2 2026Latest

Apr 24, 2026

EPS

$7.15

Est $7.12

+0.4%

Revenue

$19.1B

Est $19.1B

+0.1%

Q1 2026

Jan 27, 2026

EPS

$8.01

Est $7.46

+7.4%

Revenue

$19.5B

Est $19.7B

-0.9%

Q4 2025

Oct 24, 2025

EPS

$6.96

Est $5.79

+20.2%

Revenue

$19.2B

Est $18.6B

+3.0%

Q3 2025

Jul 25, 2025

EPS

$6.84

Est $6.29

+8.7%

Revenue

$18.6B

Est $18.5B

+0.6%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	Apr 24, 2026	$7.15vs $7.12+0.4%	$19.1Bvs $19.1B+0.1%
Q1 2026	Jan 27, 2026	$8.01vs $7.46+7.4%	$19.5Bvs $19.7B-0.9%
Q4 2025	Oct 24, 2025	$6.96vs $5.79+20.2%	$19.2Bvs $18.6B+3.0%
Q3 2025	Jul 25, 2025	$6.84vs $6.29+8.7%	$18.6Bvs $18.5B+0.6%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	FCF Yield	Debt / Equity
THCTenet Healthcare CorporationDirect Competitor	16.37B	186.91	12.07	3.12%	7.94%	19.56%	15.45%	1.47
CYHCommunity Health Systems, Inc.Direct Competitor	397.43M	2.82	0.75	-1.18%	-0.41%		52.34%
UHSUniversal Health Services, Inc.Direct Competitor	10.35B	165.40	7.16	9.71%	8.56%	20.65%	8.2%	0.74
ENSGThe Ensign Group, Inc.Direct Competitor	10.28B	175.95	30.13	18.72%	6.89%	16.61%	3.61%	1.86
SEMSelect Medical Holdings CorporationProduct Competitor	2.04B	16.44	13.93	5.12%	2.42%	6.57%	18.77%	1.82
ACHCAcadia Healthcare Company, Inc.Product Competitor	2.33B	25.27	-2.08	5.04%	-32.84%	-40.92%		1.24
SGRYSurgery Partners, Inc.Product Competitor	1.85B	14.26	-23.38	6.24%	-2.28%	-2.39%	10.6%	1.14
USPHU.S. Physical Therapy, Inc.Product Competitor	1.09B	71.74	50.52	-3.12%	5.4%	4.56%	5.59%	0.21

Compare HCA vs Peers

HCA Healthcare, Inc. (HCA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs THC

Most directly comparable listed peer for HCA.

Scale Benchmark

vs UNH

Larger-name benchmark to compare HCA against a more recognizable public peer.

Peer Set

Compare Top 5

vs THC, CYH, UHS, ENSG

HCA Income Statement

HCA Healthcare, Inc. (HCA) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Sales/Revenue	43.61B	46.68B	51.34B	51.53B	58.75B	60.23B	64.97B	70.6B	75.6B
Revenue Growth %	5.12%	7.02%	9.98%	0.38%	14.01%	2.52%	7.86%	8.67%	7.08%
Cost of Goods Sold	7.32B	7.72B	8.48B	8.37B	36.26B	37.06B	39.39B	41.92B	44.23B
COGS % of Revenue	16.77%	16.55%	16.52%	16.24%	61.72%	61.52%	60.63%	59.38%	58.5%
Gross Profit	36.3B▲ 0%	38.95B▲ 7.3%	42.85B▲ 10.0%	43.16B▲ 0.7%	22.49B▼ 47.9%	23.18B▲ 3.0%	25.58B▲ 10.4%	28.68B▲ 12.1%	31.37B▲ 9.4%
Gross Margin %	83.23%	83.45%	83.48%	83.76%	38.28%	38.48%	39.37%	40.62%	41.5%
Gross Profit Growth %	5.04%	7.31%	10.02%	0.72%	-47.89%	3.05%	10.36%	12.12%	9.4%
Operating Expenses	30.24B	32.31B	35.64B	35.9B	12.81B	14.12B	15.95B	18.13B	19.41B
OpEx % of Revenue	69.34%	69.22%	69.42%	69.67%	21.81%	23.45%	24.55%	25.68%	25.67%
Selling, General & Admin	20.06B	21.43B	23.56B	23.87B	26.78B	27.68B	29.49B	31.17B	8B
SG&A % of Revenue	45.99%	45.9%	45.89%	46.33%	45.58%	45.96%	45.39%	44.15%	10.58%
Research & Development	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-
Other Operating Expenses	10.18B	10.89B	12.08B	12.03B	-13.96B	-13.56B	-13.54B	-13.04B	11.41B
Operating Income	6.06B▲ 0%	6.64B▲ 9.7%	7.22B▲ 8.7%	7.26B▲ 0.6%	9.68B▲ 33.3%	9.05B▼ 6.5%	9.63B▲ 6.3%	10.55B▲ 9.6%	11.96B▲ 13.4%
Operating Margin %	13.89%	14.23%	14.06%	14.09%	16.47%	15.03%	14.82%	14.94%	15.83%
Operating Income Growth %	-2.27%	9.66%	8.67%	0.61%	33.27%	-6.46%	6.34%	9.56%	13.44%
EBITDA	8.19B	8.92B	9.81B	9.98B	12.53B	12.02B	12.7B	13.86B	15.49B
EBITDA Margin %	18.77%	19.11%	19.12%	19.37%	21.33%	19.96%	19.55%	19.63%	20.49%
EBITDA Growth %	0.29%	8.94%	10.02%	1.72%	25.52%	-4.06%	5.67%	9.09%	11.75%
D&A (Non-Cash Add-back)	2.13B	2.28B	2.6B	2.72B	2.85B	2.97B	3.08B	3.31B	3.52B
EBIT	6.07B	7.09B	7.07B	7.01B	11.4B	10.32B	9.64B	10.58B	12.08B
Net Interest Income	-1.67B	-1.76B	-1.84B	-1.56B	-1.53B	-1.74B	-1.94B	-2.06B	-2.25B
Interest Income	0	0	0	0	0	0	0	0	0
Interest Expense	1.67B	1.76B	1.84B	1.56B	1.53B	1.74B	1.94B	2.06B	2.25B
Other Income/Expense	-1.68B	-1.31B	-1.97B	-1.83B	155M	-473M	-1.92B	-2.02B	-2.13B
Pretax Income	4.38B▲ 0%	5.33B▲ 21.8%	5.24B▼ 1.7%	5.43B▲ 3.5%	9.83B▲ 81.1%	8.58B▼ 12.7%	7.71B▼ 10.2%	8.52B▲ 10.6%	9.83B▲ 15.4%
Pretax Margin %	10.04%	11.43%	10.22%	10.54%	16.74%	14.24%	11.86%	12.07%	13.01%
Income Tax	1.64B	946M	1.1B	1.04B	2.11B	1.75B	1.61B	1.87B	2.05B
Effective Tax Rate %	37.39%	17.73%	20.96%	19.21%	21.48%	20.35%	20.96%	21.89%	20.85%
Net Income	2.22B▲ 0%	3.79B▲ 70.9%	3.5B▼ 7.4%	3.75B▲ 7.1%	6.96B▲ 85.3%	5.64B▼ 18.9%	5.24B▼ 7.1%	5.76B▲ 9.9%	6.78B▲ 17.8%
Net Margin %	5.08%	8.11%	6.83%	7.28%	11.84%	9.37%	8.07%	8.16%	8.97%
Net Income Growth %	-23.32%	70.89%	-7.45%	7.1%	85.3%	-18.88%	-7.11%	9.88%	17.78%
Net Income (Continuing)	2.74B	4.39B	4.14B	4.39B	7.72B	6.83B	6.09B	6.66B	7.78B
Discontinued Operations	0	0	0	0	0	0	0	0	0
Minority Interest	1.81B	2.03B	2.24B	2.32B	2.42B	2.69B	2.83B	3.05B	3.26B
EPS (Diluted)	5.95▲ 0%	10.66▲ 79.2%	10.07▼ 5.5%	10.93▲ 8.5%	21.16▲ 93.6%	19.15▼ 9.5%	18.96▼ 1.0%	22.00▲ 16.0%	28.38▲ 29.0%
EPS Growth %	-18.49%	79.16%	-5.53%	8.54%	93.6%	-9.5%	-0.99%	16.03%	29%
EPS (Basic)	6.33	11.04	10.27	11.08	21.51	19.44	19.24	22.27	28.62
Diluted Shares Outstanding	372.22M	355.3M	348.23M	345.37M	328.75M	294.67M	276.41M	261.81M	230.71M
Basic Shares Outstanding	350.09M	342.9M	341.21M	339.43M	323.31M	290.35M	272.4M	258.6M	230.71M
Dividend Payout Ratio	-	12.86%	15.69%	4.08%	8.97%	11.57%	12.61%	11.98%	10.01%

HCA Balance Sheet

HCA Healthcare, Inc. (HCA) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Total Current Assets	9.98B	10.21B	11.2B	12.33B	13.54B	13.64B	14.93B	16.41B	13.56B
Cash & Short-Term Investments	732M	502M	621M	1.79B	1.45B	908M	935M	2.02B	1.04B
Cash Only	732M	502M	621M	1.79B	1.45B	908M	935M	1.93B	1.04B
Short-Term Investments	0	0	0	0	0	0	0	88M	0
Accounts Receivable	6.5B	6.79B	7.38B	7.05B	8.1B	8.89B	9.96B	10.75B	10.87B
Days Sales Outstanding	54.41	53.09	52.47	49.94	50.29	53.88	55.95	55.58	52.47
Inventory	1.57B	1.73B	1.85B	2.02B	1.99B	2.07B	2.02B	1.74B	1.65B
Days Inventory Outstanding	78.48	81.85	79.58	88.32	19.99	20.37	18.73	15.13	13.63
Other Current Assets	1.17B	1.19B	1.35B	1.46B	2.01B	1.78B	2.01B	1.9B	0
Total Non-Current Assets	26.62B	28.99B	33.86B	35.16B	37.2B	38.8B	41.28B	43.1B	47.16B
Property, Plant & Equipment	17.89B	19.76B	24.55B	25.22B	26.18B	27.64B	29.92B	31.55B	31.14B
Fixed Asset Turnover	2.44x	2.36x	2.09x	2.04x	2.24x	2.18x	2.17x	2.24x	2.43x
Goodwill	7.04B	7.61B	7.94B	8.21B	9.14B	9.29B	9.61B	9.77B	0
Intangible Assets	359M	342M	330M	369M	403M	359M	339M	323M	10.29B
Long-Term Investments	617M	594M	564M	810M	886M	1.2B	1.23B	1.23B	633M
Other Non-Current Assets	710M	690M	480M	546M	598M	298M	184M	230M	5.09B
Total Assets	36.59B▲ 0%	39.21B▲ 7.1%	45.06B▲ 14.9%	47.49B▲ 5.4%	50.74B▲ 6.8%	52.44B▲ 3.3%	56.21B▲ 7.2%	59.51B▲ 5.9%	60.72B▲ 2.0%
Asset Turnover	1.19x	1.19x	1.14x	1.09x	1.16x	1.15x	1.16x	1.19x	1.25x
Asset Growth %	8.4%	7.14%	14.92%	5.4%	6.85%	3.34%	7.2%	5.87%	2.03%
Total Current Liabilities	6.16B	7.57B	7.76B	8.7B	9.58B	9.9B	12.65B	15.18B	16.35B
Accounts Payable	2.61B	2.58B	2.9B	3.54B	4.11B	4.24B	4.23B	4.28B	4.66B
Days Payables Outstanding	130.01	121.78	125.02	154.17	41.38	41.75	39.23	37.23	38.45
Short-Term Debt	200M	788M	145M	209M	237M	370M	2.42B	4.7B	6.74B
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0
Other Current Liabilities	67M	459M	528M	547M	549M	794M	867M	910M	2.42B
Current Ratio	1.62x	1.35x	1.44x	1.42x	1.41x	1.38x	1.18x	1.08x	0.83x
Quick Ratio	1.36x	1.12x	1.20x	1.18x	1.21x	1.17x	1.02x	0.97x	0.73x
Cash Conversion Cycle	2.87	13.16	7.02	-15.91	28.9	32.49	35.45	33.48	27.65
Total Non-Current Liabilities	35.43B	34.56B	37.87B	35.89B	39.67B	42.61B	42.5B	43.78B	47.14B
Long-Term Debt	32.86B	32.03B	33.58B	30.8B	33.77B	37.13B	37.17B	38.33B	41.6B
Capital Lease Obligations	0	0	1.5B	1.67B	2.33B	2.33B	1.9B	1.86B	1.85B
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	2.57B	2.52B	2.79B	3.43B	3.57B	3.14B	3.42B	3.58B	3.69B
Total Liabilities	41.59B	42.13B	45.62B	44.6B	49.25B	52.51B	55.15B	58.96B	63.49B
Total Debt	33.06B	32.82B	35.57B	33.06B	36.73B	40.2B	41.86B	45.24B	50.2B
Net Debt	32.33B	32.32B	34.95B	31.26B	35.27B	39.29B	40.92B	43.3B	49.16B
Debt / Equity	-	-	-	11.43x	24.66x	-	39.49x	81.51x	-
Debt / EBITDA	4.04x	3.68x	3.62x	3.31x	2.93x	3.34x	3.29x	3.26x	3.24x
Net Debt / EBITDA	3.95x	3.62x	3.56x	3.13x	2.82x	3.27x	3.22x	3.12x	3.17x
Interest Coverage	3.64x	4.02x	3.84x	4.50x	7.46x	5.94x	4.98x	5.14x	5.37x
Total Equity	-5B▲ 0%	-2.92B▲ 41.6%	-565M▲ 80.6%	2.89B▲ 611.9%	1.49B▼ 48.5%	-73M▼ 104.9%	1.06B▲ 1552.1%	555M▼ 47.6%	-2.77B▼ 599.3%
Equity Growth %	11.33%	41.58%	80.64%	611.86%	-48.51%	-104.9%	1552.05%	-47.64%	-599.28%
Book Value per Share	-13.42	-8.21	-1.62	8.37	4.53	-0.25	3.83	2.12	-12.01
Total Shareholders' Equity	-6.81B	-4.95B	-2.81B	572M	-933M	-2.77B	-1.77B	-2.5B	-6.03B
Common Stock	4M	3M	3M	3M	3M	3M	3M	3M	2M
Retained Earnings	-6.53B	-4.57B	-2.35B	777M	-532M	-2.28B	-1.35B	-2.12B	-5.72B
Treasury Stock	0	0	0	0	0	0	0	0	0
Accumulated OCI	-278M	-381M	-460M	-502M	-404M	-490M	-425M	-387M	-305M
Minority Interest	1.81B	2.03B	2.24B	2.32B	2.42B	2.69B	2.83B	3.05B	3.26B

HCA Cash Flow Statement

HCA Healthcare, Inc. (HCA) cash flow — operating, investing & free cash flow history

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Cash from Operations	5.43B	6.76B	7.6B	9.23B	8.96B	8.52B	9.43B	10.51B	12.64B
Operating CF Margin %	12.44%	14.48%	14.81%	17.91%	15.25%	14.15%	14.52%	14.89%	16.71%
Operating CF Growth %	-4.02%	24.6%	12.44%	21.44%	-2.96%	-4.88%	10.67%	11.48%	20.18%
Net Income	2.74B	4.39B	4.14B	4.39B	7.72B	6.83B	5.24B	6.66B	6.78B
Depreciation & Amortization	2.13B	2.28B	2.6B	2.72B	2.85B	2.97B	3.08B	3.31B	3.52B
Stock-Based Compensation	270M	268M	347M	362M	440M	341M	262M	360M	0
Deferred Taxes	433M	74M	250M	41M	-70M	571M	229M	22M	0
Other Non-Cash Items	145M	-281M	352M	443M	-1.48B	-1.04B	1.08B	269M	1.6B
Working Capital Changes	-296M	33M	-88M	1.28B	-503M	-1.15B	-457M	-106M	728M
Change in Receivables	-4.64B	-423M	-326M	327M	-962M	-797M	0	-799M	-94M
Change in Inventory	-69M	-242M	-158M	-304M	-540M	-59M	0	334M	-154M
Change in Payables	374M	698M	396M	1.25B	999M	-296M	0	359M	666M
Cash from Investing	-4.28B	-3.9B	-5.72B	-3.39B	-2.64B	-3.39B	-5.32B	-4.93B	-4.99B
Capital Expenditures	-3.02B	-3.57B	-4.16B	-2.83B	-3.58B	-4.39B	-4.74B	-4.88B	-4.94B
CapEx % of Revenue	6.91%	7.65%	8.1%	5.5%	6.09%	7.3%	7.3%	6.9%	6.54%
Acquisitions	-1.21B	-445M	-1.62B	-500M	1.05B	1.01B	-442M	0	-128M
Investments	-	-	-	-	-	-	-	-	-
Other Investing	-52M	60M	59M	-58M	-121M	-7M	-131M	-58M	12M
Cash from Financing	-1.06B	-3.08B	-1.77B	-4.68B	-6.66B	-5.66B	-4.09B	-4.58B	-8.55B
Debt Issued (Net)	1.51B	-344M	567M	-3.22B	3.25B	3.29B	1.29B	3.21B	3.21B
Equity Issued (Net)	-2.05B	-1.53B	-1.03B	-441M	-8.21B	-7B	-3.81B	-6.04B	-10.07B
Dividends Paid	0	-487M	-550M	-153M	-624M	-653M	-661M	-690M	-679M
Share Repurchases	-2.05B	-1.53B	-1.03B	-441M	-8.21B	-7B	-3.81B	-6.04B	-10.07B
Other Financing	-519M	-714M	-757M	-866M	-1.07B	-1.29B	-917M	-1.05B	-1.01B
Net Change in Cash	86M▲ 0%	-230M▼ 367.4%	119M▲ 151.7%	1.17B▲ 884.9%	-342M▼ 129.2%	-543M▼ 58.8%	27M▲ 105.0%	998M▲ 3596.3%	-893M▼ 189.5%
Free Cash Flow	2.41B▲ 0%	3.19B▲ 32.2%	3.44B▲ 8.0%	6.4B▲ 85.7%	5.38B▼ 15.9%	4.13B▼ 23.3%	4.69B▲ 13.6%	5.64B▲ 20.3%	7.69B▲ 36.4%
FCF Margin %	5.53%	6.83%	6.71%	12.41%	9.16%	6.85%	7.21%	7.99%	10.17%
FCF Growth %	-16.66%	32.23%	8.03%	85.74%	-15.87%	-23.32%	13.57%	20.31%	36.41%
FCF per Share	6.48	8.97	9.89	18.52	16.37	14.01	16.96	21.54	33.34
FCF Conversion (FCF/Net Income)	2.45x	1.79x	2.17x	2.46x	1.29x	1.51x	1.80x	1.83x	1.86x
Interest Paid	1.7B	1.74B	1.91B	1.61B	1.5B	1.66B	1.89B	1.94B	0
Taxes Paid	1.21B	872M	849M	1B	2.18B	1.18B	1.39B	1.84B	0

HCA Key Ratios

HCA Healthcare, Inc. (HCA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	-	-	-	-	322.65%	317.55%	797.03%	1062.21%	713.31%	-
Return on Invested Capital (ROIC)	19.05%	17.33%	17.56%	16.97%	15.89%	20.47%	17.87%	17.78%	18.43%	19.89%
Gross Margin	83.29%	83.23%	83.45%	83.48%	83.76%	38.28%	38.48%	39.37%	40.62%	41.5%
Net Margin	6.97%	5.08%	8.11%	6.83%	7.28%	11.84%	9.37%	8.07%	8.16%	8.97%
Debt / Equity	-	-	-	-	11.43x	24.66x	-	39.49x	81.51x	-
Interest Coverage	4.08x	3.64x	4.02x	3.84x	4.50x	7.46x	5.94x	4.98x	5.14x	5.37x
FCF Conversion	1.96x	2.45x	1.79x	2.17x	2.46x	1.29x	1.51x	1.80x	1.83x	1.86x
Revenue Growth	4.57%	5.12%	7.02%	9.98%	0.38%	14.01%	2.52%	7.86%	8.67%	7.08%

HCA SEC Filings & Documents

HCA Healthcare, Inc. (HCA) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Apr 24, 2026·SEC

Material company update

Feb 25, 2026·SEC

Material company update

Jan 27, 2026·SEC

10-K Annual Reports

FY 2026

Feb 10, 2026·SEC

FY 2025

Feb 14, 2025·SEC

FY 2024

Feb 16, 2024·SEC

10-Q Quarterly Reports

FY 2025

Oct 30, 2025·SEC

FY 2025

Aug 4, 2025·SEC

FY 2025

May 1, 2025·SEC

HCA Frequently Asked Questions

HCA Healthcare, Inc. (HCA) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

HCA Healthcare, Inc. (HCA) reported $75.60B in revenue for fiscal year 2025. This represents a 280% increase from $19.91B in 1996.

HCA Healthcare, Inc. (HCA) grew revenue by 7.1% over the past year. This is steady growth.

Yes, HCA Healthcare, Inc. (HCA) is profitable, generating $6.78B in net income for fiscal year 2025 (9.0% net margin).

Dividend & Returns

Yes, HCA Healthcare, Inc. (HCA) pays a dividend with a yield of 0.69%. This makes it attractive for income-focused investors.

HCA Healthcare, Inc. (HCA) generated $7.69B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More HCA

HCA Healthcare, Inc. (HCA) financial analysis — history, returns, DCA and operating performance tools

Full HCA Stock Analysis

Analyst verdict, bull/bear case, risk factors and peer comparison

→

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

HCA Healthcare, Inc.(HCA)Earnings, Financials & Key Ratios

HCA Key Insights

✓Strengths

✗Weaknesses

HCA Price & Volume

HCA Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

HCA Recent Earnings

HCA Peer Comparison

Compare HCA vs Peers

vs THC

vs UNH

Compare Top 5

HCA Income Statement

HCA Balance Sheet

HCA Cash Flow Statement

HCA Key Ratios

HCA SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

HCA Frequently Asked Questions

Explore More HCA

Full HCA Stock Analysis

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation